British Pharmaceuticals & Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 214.28%
- Profit Growth 160.76%
- Ebitda 161.53%
- Net Worth 11.57%
- Total Assets 30.70%
About British Pharmaceuticals & Chemicals India
British Pharmaceuticals & Chemicals India Private Limited (BPCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2016 (Eight years and 11 months 13 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anandhi Akilan and Akilan Ramnathan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TN2016PTC104234
-
Company No.
104234
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Feb 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at British Pharmaceuticals & Chemicals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akilan Ramnathan
|
Managing Director | 19-Feb-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anandhi Akilan
|
Director | 19-Feb-2016 | Current |
Financial Performance of British Pharmaceuticals & Chemicals India.
British Pharmaceuticals & Chemicals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 214.28% increase. The company also saw a substantial improvement in profitability, with a 160.76% increase in profit. The company's net worth Soared by an impressive increase of 11.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of British Pharmaceuticals & Chemicals India?
In 2019, British Pharmaceuticals & Chemicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
British Agro Products (India) Private LimitedAnandhi Akilan and Akilan Ramnathan are mutual person
-
Blue Silicon Infotech Private Limited
Anandhi Akilan is a mutual person
-
Hibiscus Foundation For Social Welfare
Anandhi Akilan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at British Pharmaceuticals & Chemicals India?
Unlock and access historical data on people associated with British Pharmaceuticals & Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of British Pharmaceuticals & Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped British Pharmaceuticals & Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.